Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients

Purpose Idiopathic pulmonary fibrosis (IPF) is an inexorably progressive disease, which has a great impact on patients' lives. Pirfenidone and nintedanib are approved and recommended antifibrotic drugs for patients with IPF. The aim of this study was to evaluate self-reported gastrointestinal side effects of antifibrotic drugs in 176 Dutch IPF patients. Methods A cross-sectional web-based anonymous survey about complaints and side effects was conducted among IPF patients in the Netherlands. Logistic regression was used to quantify whether pirfenidone and nintedanib caused complaints of nausea,... Mehr ...

Verfasser: Proesmans, V. L. J.
Drent, M.
Elfferich, M. D. P.
Wijnen, P. A. H. M.
Jessurun, N. T.
Bast, A.
Dokumenttyp: Artikel
Erscheinungsdatum: 2019
Reihe/Periodikum: Proesmans , V L J , Drent , M , Elfferich , M D P , Wijnen , P A H M , Jessurun , N T & Bast , A 2019 , ' Self-reported Gastrointestinal Side Effects of Antifibrotic Drugs in Dutch Idiopathic Pulmonary Fibrosis patients ' , Lung , vol. 197 , no. 5 , pp. 551-558 . https://doi.org/10.1007/s00408-019-00260-1
Schlagwörter: Antifibrotic drugs / Idiopathic pulmonary fibrosis / IPF / Nintedanib / Pirfenidone / Side effects / Treatment / CLINICAL-PRACTICE / DIAGNOSIS / DISEASE / MANAGEMENT / SAFETY
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27051909
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/6c887f32-8531-489b-b795-9813e9ce65fe